Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/10/2021 06/11/2021 06/14/2021 06/15/2021 06/16/2021 Date
217(c) 218.85(c) 207.41(c) 201.59(c) 197.84(c) Last
11 763 149 5 576 026 11 743 700 6 786 260 7 264 747 Volume
-0.20% +0.85% -5.23% -2.81% -1.86% Change
More quotes
Financials (USD)
Sales 2021 18 664 M - -
Net income 2021 10 397 M - -
Net cash position 2021 11 520 M - -
P/E ratio 2021 8,02x
Yield 2021 -
Sales 2022 15 893 M - -
Net income 2022 7 759 M - -
Net cash position 2022 20 906 M - -
P/E ratio 2022 11,2x
Yield 2022 -
Capitalization 79 438 M 79 438 M -
EV / Sales 2021 3,64x
EV / Sales 2022 3,68x
Nbr of Employees 1 300
Free-Float 90,3%
More Financials
Company
Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for infectious, autoimmune and cardiovascular diseases. Turnover per type of income can be broken down as follows: - Collaboration revenue (79.8%); - Grant revenue (20.2%). At the end of 2019, the group possessed a portfolio of 6 development candidates in clinical studies, with three in phase II and... 
More about the company
Ratings of Moderna, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about MODERNA, INC.
06/16CureVac fails in pivotal COVID-19 vaccine trial with 47% efficacy
RE
06/16MODERNA  : Manitoba to expand its COVID-19 vaccine effort with large Moderna sup..
AQ
06/16MODERNA  : U.S. administers 312.9 mln doses of COVID-19 vaccines - CDC
RE
06/16MODERNA  : U.S. CDC Says 146,456,124 Individuals Have Been Fully Vaccinated Agai..
RE
06/16MODERNA  : COVID-19 vaccine prevented 95% of new infections after one dose in st..
AQ
06/16WALL STREET STOCK EXCHANGE : How yesterday’s data could affect Fed policy
06/16MODERNA  : To Supply Further 200 Million COVID-19 Vaccine Doses To US
MT
06/16MODERNA  : Gets Order of 200 Million More Doses of Its COVID-19 Vaccine From US ..
MT
06/16MODERNA  : U.S. Government Purchases Additional 200 Million Doses of Moderna's C..
BU
06/16UK Vaccination Rate Slows Down On Shortage Of Pfizer Jabs
MT
06/15US, EU Vow to Provide COVID-19 Vaccine to Two-Thirds of World's Population by..
MT
06/15MODERNA  : U.S. administers nearly 311.9 mln doses of COVID-19 vaccines - CDC
RE
06/15MODERNA  : U.S. CDC Says Administered 311,886,674 Doses Of COVID-19 Vaccine As O..
RE
06/15Moderna Signs COVID-19 Vaccine Distribution Deal In UAE
MT
06/15MODERNA  : Taps Magenta Investments As UAE Distributor For COVID-19 Vaccine
MT
More news
News in other languages on MODERNA, INC.
06/16CORONA-BLOG/Spahn erwartet Erstimpfung aller Impfwilligen Anfang August
06/16MODERNA  : Washington commande 200 millions de doses en plus
06/16MODERNA : Washington achète 200 millions de doses supplémentaires de son vaccin
06/16WALL STREET STOCK EXCHANGE : Cómo podrían afectar los datos de ayer a la polític..
06/16Les valeurs à suivre aujourd'hui à Wall Street Mercredi 16 juin 2021
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Stock Trading Strategies
MODERNA, INC. - 2020
The beginning of the move
BUY
More Stock Trading Analysis
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 168,87 $
Last Close Price 197,84 $
Spread / Highest target 24,3%
Spread / Average Target -14,6%
Spread / Lowest Target -58,0%
EPS Revisions
Managers and Directors
NameTitle
Stéphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capitalization (M$)
MODERNA, INC.89.37%80 944
LONZA GROUP AG16.07%54 601
IQVIA HOLDINGS INC.36.31%47 315
CELLTRION, INC.-24.37%33 588
SEAGEN INC.-13.60%27 797
HANGZHOU TIGERMED CONSULTING CO., LTD10.14%24 192